Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. decreased its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 7.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,193 shares of the company’s stock after selling 1,890 shares during the quarter. Corebridge Financial Inc. owned 0.05% of Avanos Medical worth $385,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. The Manufacturers Life Insurance Company increased its holdings in Avanos Medical by 34.2% in the third quarter. The Manufacturers Life Insurance Company now owns 22,996 shares of the company’s stock valued at $553,000 after buying an additional 5,859 shares in the last quarter. FMR LLC increased its stake in shares of Avanos Medical by 34.6% in the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock valued at $3,216,000 after purchasing an additional 34,421 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Avanos Medical by 12.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock valued at $2,607,000 after purchasing an additional 11,613 shares in the last quarter. Quarry LP purchased a new position in Avanos Medical during the third quarter worth approximately $42,000. Finally, Jane Street Group LLC grew its holdings in Avanos Medical by 35.8% in the third quarter. Jane Street Group LLC now owns 65,650 shares of the company’s stock valued at $1,578,000 after purchasing an additional 17,306 shares during the period. 95.17% of the stock is owned by hedge funds and other institutional investors.

Avanos Medical Price Performance

NYSE:AVNS opened at $13.16 on Thursday. The firm has a market cap of $605.17 million, a P/E ratio of 38.69 and a beta of 1.15. The stock has a 50 day moving average of $15.04 and a two-hundred day moving average of $17.65. Avanos Medical, Inc. has a 12 month low of $12.09 and a 12 month high of $25.36. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS) last announced its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. The company had revenue of $179.60 million for the quarter, compared to analysts’ expectations of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. On average, analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Insider Activity at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now owns 82,047 shares of the company’s stock, valued at $1,251,216.75. This trade represents a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.64% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.